Skip to main content



Cees Kallenberg

  1. Review

    Progress in treatment of ANCA-associated vasculitis

    Autoantibodies to neutrophil cytoplasmic antigen-associated vasculitis (AAV) is characterised by inflammation of blood vessels. The introduction of immunosuppressive therapy with glucocorticoids and cyclophosp...

    Rona M Smith, Rachel B Jones and David RW Jayne

    Arthritis Research & Therapy 2012 14:210

    Published on: 30 April 2012

  2. Review

    T-helper cells as new players in ANCA-associated vasculitides

    In anti-neutrophil cytoplasmic autoantibody-associated vasculitides (AAV), several observations support a key role of T-helper cells (CD4+ T cells) in disease pathophysiology. An expanded population of effector m...

    Wayel H Abdulahad, Peter Lamprecht and Cees GM Kallenberg

    Arthritis Research & Therapy 2011 13:236

    Published on: 23 August 2011

  3. Review

    Giant cell arteritis: immune and vascular aging as disease risk factors

    Susceptibility for giant cell arteritis increases with chronological age, in parallel with age-related restructuring of the immune system and age-induced remodeling of the vascular wall. Immunosenescence resul...

    Shalini V Mohan, Y Joyce Liao, Jonathan W Kim, Jörg J Goronzy and Cornelia M Weyand

    Arthritis Research & Therapy 2011 13:231

    Published on: 2 August 2011